Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

NCT00679367 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: dexamethasone
DRUG: lenalidomide
DRUG: melphalan

Sponsor

Boston Medical Center